ZBH

Zimmer Biomet Holdings Inc

Healthcare


Presented:07/01/2021
Price:$163.14
Cap:$34.01B
Current Price:$104.60
Cap:$21.30B

Presented

Date07/01/2021
Price$163.14
Market Cap$34.01B
Ent Value$40.77B
P/E Ratio60.4x
Book Value$59.72
Div Yield0.59%
Shares O/S208.48M
Ave Daily Vol1,154,371
Short Int0.89%

Current

Price$104.60
Market Cap$21.30B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It operates through the following segments: Americas and Global Businesses, EMEA, and Asia Pacific. The Americas and Global Businesses segment consists of U.S. and includes other North, Central and South American markets for all product categories as well as the global results for the Dental products division. The EMEA segment focuses in Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment comprises of Japan, China and Australia and includes other Asian and Pacific markets for all product categories except Dental. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Publicly traded companies mentioned herein: Stryker Corp (SYK), Zimmer Biomet Holdings Inc (ZBH)

Highlights

The presenter is long shares of Zimmer Biomet Holdings Inc (ZBH), which he feels is set up well for the next 12 – 18 months. He believes ZBH is a reopening trade but notes that it has been roughly flattish YTD, whereas sell-side reopening baskets he follows are up ~27%. It is now trading at 20x earnings but has traded as high as the mid-30x range in the past. As numbers during the second half of 2021 show normalizing trends, he expects the stock to trade up as the company beats consensus numbers. 

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.